Publications in collaboration with researchers from Hospital Universitario Doctor Peset (154)

2024

  1. Beyond Weight Loss: Evaluating Cardiovascular Advantages of GLP-1 Receptor Agonists

    American Journal of Cardiovascular Drugs

  2. Cardiovascular benefits of SGLT2 inhibitors and GLP-1 receptor agonists through effects on mitochondrial function and oxidative stress

    Free Radical Biology and Medicine, Vol. 213, pp. 19-35

  3. Circadian alignment of food intake and glycaemic control by time-restricted eating: A systematic review and meta-analysis

    Reviews in Endocrine and Metabolic Disorders, Vol. 25, Núm. 2, pp. 325-337

  4. Inflammation and weight change related to neurocognitive and functional impairment in diabetes and psychiatric disorders

    Spanish Journal of Psychiatry and Mental Health

  5. SIRT1 and miR-34a-5p: Valuable Biomarkers for the Early Detection of Cognitive Impairment in Type 2 Diabetes Mellitus

    Journal of Clinical Endocrinology and Metabolism

  6. Systemic inflammation, oxidative damage and neurocognition predict telomere length in a transdiagnostic sample stratified by global DNA methylation levels

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. Effects of GLP-1 receptor agonists on mitochondrial function, inflammatory markers and leukocyte-endothelium interactions in type 2 diabetes

    Redox biology, Vol. 66, pp. 102849

  2. Inflammation and lipid metabolism as potential biomarkers of memory impairment across type 2 diabetes mellitus and severe mental disorders

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 127

  3. Mitochondrial Dysfunction and Mitophagy in Type 2 Diabetes: Pathophysiology and Therapeutic Targets

    Antioxidants and Redox Signaling, Vol. 39, Núm. 4-6, pp. 278-320

2022

  1. Glycated Proteins, Glycine, Acetate, and Monounsaturated Fatty Acids May Act as New Biomarkers to Predict the Progression of Type 2 Diabetes: Secondary Analyses of a Randomized Controlled Trial

    Nutrients, Vol. 14, Núm. 23

  2. Gold Nanoparticles Supported on Ceria Nanoparticles Modulate Leukocyte–Endothelium Cell Interactions and Inflammation in Type 2 Diabetes

    Antioxidants, Vol. 11, Núm. 11

  3. Immune–Inflammatory Biomarkers Predict Cognition and Social Functioning in Patients With Type 2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: A 1-Year Follow-Up Study

    Frontiers in Neurology, Vol. 13

  4. Impact of Roux-en-Y Gastric Bypass on Mitochondrial Biogenesis and Dynamics in Leukocytes of Obese Women

    Antioxidants, Vol. 11, Núm. 7

  5. Impact of nitric oxide in liver cancer microenvironment

    Nitric Oxide - Biology and Chemistry, Vol. 128, pp. 1-11

  6. Metformin modulates mitochondrial function and mitophagy in peripheral blood mononuclear cells from type 2 diabetic patients

    Redox Biology, Vol. 53

  7. Metformin: An Intriguing Protective Agent in Hospitalized Diabetic Patients With Sepsis

    Critical care medicine, Vol. 50, Núm. 6, pp. 1018-1020

  8. Mitochondrial redox impairment and enhanced autophagy in peripheral blood mononuclear cells from type 1 diabetic patients

    Redox Biology, Vol. 58

  9. Roux-en-Y Gastric Bypass Modulates AMPK, Autophagy and Inflammatory Response in Leukocytes of Obese Patients

    Biomedicines, Vol. 10, Núm. 2

  10. Specific metabolic syndrome components predict cognition and social functioning in people with type 2 diabetes mellitus and severe mental disorders

    Acta Psychiatrica Scandinavica, Vol. 146, Núm. 3, pp. 215-226

  11. The Role of Mitochondrial Dynamic Dysfunction in Age-Associated Type 2 Diabetes

    World Journal of Men's Health, Vol. 40